Sign in

ALGN on Nasdaq

Align Technology

Logo: Align Technology, Public domain, via Wikimedia Commons5

American company that produces orthodontics devices

Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China.3 Its shares trade on Nasdaq under the symbol ALGN.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1997Founded1

Compare with Steris, Edwards Lifesciences or Colfax Corporation, or pick any stock.

  • TickerALGN on Nasdaq1
  • IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies1
  • HeadquartersSan Jose1
  • Websitewww.aligntech.com
  • Legal formDelaware corporation1
  • Incorporated inDE6
  • Business address410 North Scottsdale Road, Suite 1300, Tempe, Az 852886
  • Filer categoryLarge accelerated filer6
  • LEI549300N5YSE0U3LCP8404
  • StatusActive4
  • LEI statusIssued and current4
  • Registered address251 LITTLE FALLS DRIVE, 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 27365544

See how the biggest companies compare on our leaderboards

Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

67.2%Gross margin8
13.5%Operating margin8
10.2%Net margin8
0.9%Revenue growth, 20258
10.1%Return on equity8
$490.8MFree cash flow8

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Clear Aligner brought in 80% of the revenue Align Technology broke down this way in fiscal 2025.

  1. Clear Aligner$3.2B880%up 0% from 2024
  2. Systems And Services$789.6M820%up 3% from 2024
Business segments by year
Business segments202320242025
Clear Aligner$3.2B$3.2B$3.2B
Systems And Services$662.9M$768.9M$789.6M

Regions

United States brought in 41% of the revenue Align Technology broke down this way in fiscal 2025.

  1. United States$1.7B841%down 2% from 2024
  2. Other International$1.5B836%up 10% from 2024
  3. Switzerland$920.6M823%down 6% from 2024
Regions by year
Regions202320242025
United States$1.7B$1.7B$1.7B
Other International$1.0B$1.3B$1.5B
Switzerland$1.2B$983.6M$920.6M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue33¢$1.3B
  • Research and development9¢$369.9M
  • Selling, general and admin44¢$1.8B
  • Income tax4¢$174.9M
  • Profit10¢$410.4M

Out of $4.0B in revenue.8

Where each dollar of operating cash went, fiscal 2025

  • Capital spending17¢$102.4M
  • Share buybacks79¢$465.9M
  • Kept or used elsewhere4¢$24.8M

Out of $593.2M of cash from operations.8

Financial statements

Revenue91011128$4.0B in 2025+68% since 2019
0$2.0B$4.0B$6.0B2019: $2.4B$2.4B20192020: $2.5B$2.5B2020+3%2021: $4.0B$4.0B2021+60%2022: $3.7B$3.7B2022−6%2023: $3.9B$3.9B2023+3%2024: $4.0B$4.0B2024+4%2025: $4.0B$4.0B2025+1%
Gross profit91011128$2.7B in 2025+55% since 2019
0$1.0B$2.0B$3.0B2019: $1.7B$1.7B20192020: $1.8B$1.8B2020+1%2021: $2.9B$2.9B2021+66%2022: $2.6B$2.6B2022−10%2023: $2.7B$2.7B2023+3%2024: $2.8B$2.8B2024+3%2025: $2.7B$2.7B2025−3%
Operating income91011128$545.8M in 2025+1% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $542.5M$542.5M20192020: $387.2M$387.2M2020−29%2021: $976.4M$976.4M2021+152%2022: $642.6M$642.6M2022−34%2023: $643.3M$643.3M2023+0%2024: $607.6M$607.6M2024−6%2025: $545.8M$545.8M2025−10%
Net income91011128$410.4M in 2025−7% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $442.8M$442.8M20192020: $1.8B$1.8B2020+301%2021: $772.0M$772.0M2021−57%2022: $361.6M$361.6M2022−53%2023: $445.1M$445.1M2023+23%2024: $421.4M$421.4M2024−5%2025: $410.4M$410.4M2025−3%

Every line of the income statement as filed: the last 3 fiscal years, latest first.8

Period ending2025-12-312024-12-312023-12-31
Net revenues$4.0B$4.0B$3.9B
Cost of net revenues$1.3B$1.2B$1.2B
Gross profit$2.7B$2.8B$2.7B
Selling, general and administrative$1.8B$1.8B$1.7B
Research and development$369.9M$364.2M$346.8M
Restructuring and other charges$35.4M$33.2M$13.3M
Legal settlement loss$4.2M$31.0M$0
Total operating expenses$2.2B$2.2B$2.1B
Income from operations$545.8M$607.6M$643.3M
Interest income$16.0M$20.2M$17.3M
Other income (expense), net$23.5M-$18.9M-$19.4M
Total interest income and other income (expense), net$39.5M$1.3M-$2.1M
Net income before provision for income taxes$585.3M$609.0M$641.2M
Income Tax expense$174.9M$187.6M$196.2M
Net income$410.4M$421.4M$445.1M
Net income per share, basic (usd per share)$5.66$5.63$5.82
Diluted (usd per share)$5.65$5.62$5.81
Basic (shares)72.5M shares74.9M shares76.4M shares
Diluted (shares)72.6M shares75.0M shares76.6M shares

Compare Align Technology with another company

Corporate structure

Align Technology sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Align Technology

  • Capital World Investors Filed SCHEDULE 13G/A on Align Technology, latest Aug 12, 2026 (2 filings since May 14, 2026)
  • G. Zachary Gund Filed SCHEDULE 13G/A on Align Technology, latest Aug 12, 2026 (2 filings since Jan 27, 2025)
  • FMR LLC Filed SCHEDULE 13G on Align Technology, latest Aug 6, 2026
  • Capital International Investors Filed SCHEDULE 13G/A on Align Technology, latest May 14, 2026 (2 filings since Feb 13, 2026)
  • VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Align Technology, latest Apr 29, 2026
  • VANGUARD GROUP INC Filed SCHEDULE 13G/A on Align Technology, latest Mar 26, 2026 (5 filings since Feb 9, 2022)
  • BlackRock Filed SCHEDULE 13G/A on Align Technology, latest Jan 21, 2026 (6 filings since Feb 3, 2022)
  • Gordon Gund Filed SC 13G/A on Align Technology, latest Feb 9, 2024 (3 filings since Feb 7, 2022)
  • EDGEWOOD MANAGEMENT LLC Filed SC 13G/A on Align Technology, latest Feb 14, 2023 (2 filings since Feb 14, 2022)
  • Align Technology Wilmington, Delaware, United States
    • ALIGNTECH DE MEXICO S DE RL DE CV Branch · Wilmington, Delaware, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Align Technology reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Computer equipment and software$38.5M8 Dec 31, 2025$23.1M8 Dec 31, 2024+66.7%
Property and equipment, before depreciation$1.9B8 Dec 31, 2025$1.9B8 Dec 31, 2024−1.8%
Accumulated depreciation$767.3M8 Dec 31, 2025$661.7M8 Dec 31, 2024+16.0%
Property and equipment, net$1.1B8 Dec 31, 2025$1.3B8 Dec 31, 2024−11.0%
Operating-lease assets (leased space)$108.3M8 Dec 31, 2025$113.4M8 Dec 31, 2024−4.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$1.1B8 Dec 31, 2025$1.0B8 Dec 31, 2024+4.9%
Marketable securities, current$012 Dec 31, 2024$35.3M12 Dec 31, 2023−100.0%
Marketable securities, non-current$012 Dec 31, 2024$8.0M12 Dec 31, 2023−100.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$491.8M8 Dec 31, 2025$442.6M8 Dec 31, 2024+11.1%
Intangible assets, net (excluding goodwill)$93.9M8 Dec 31, 2025$103.5M8 Dec 31, 2024−9.2%
Finite-lived intangibles, gross$178.4M8 Dec 31, 2025$185.2M8 Dec 31, 2024−3.7%
Accumulated amortization$87.9M8 Dec 31, 2025$71.9M8 Dec 31, 2024+22.3%
Finite-lived intangibles, net$93.9M8 Dec 31, 2025$103.5M8 Dec 31, 2024−9.2%

Inventory

ItemLatestA year beforeChange
Inventory, total$226.3M8 Dec 31, 2025$254.3M8 Dec 31, 2024−11.0%
Raw materials$107.3M8 Dec 31, 2025$124.4M8 Dec 31, 2024−13.7%
Work in process$65.7M8 Dec 31, 2025$73.7M8 Dec 31, 2024−10.8%
Finished goods$53.4M8 Dec 31, 2025$56.2M8 Dec 31, 2024−5.1%

Properties, in its own words

We occupy several leased and owned facilities. As of December 31, 2025, the significant facilities occupied were as follows:

Location · Lease/Own · Primary Use

The rest of Item 2

Tempe, Arizona, U.S.A. · Lease · Office for corporate headquarters

San Jose, California, U.S.A. · Own · Office for research & development and administrative personnel

Raleigh, North Carolina, U.S.A. · Own · Office for Americas regional headquarters

Belen, Heredia, Costa Rica · Own · Office for administrative personnel, treatment personnel, and customer care

La Lima, Cartago, Costa Rica · Own · Office for administrative personnel, treatment personnel, and customer care

Wroclaw, Poland · Lease and Own · Manufacturing and office for treatment and administrative personnel

Petah Tikva, Israel · Lease and Own · Manufacturing and office for research & development and administrative personnel

Rotkreuz, Switzerland · Lease · Office for EMEA regional headquarters

Juarez, Mexico · Own · Manufacturing and office for administrative personnel

Guoco Midtown, Singapore · Lease · Office for APAC regional headquarters

Ziyang, China · Own · Manufacturing and office for administrative personnel

We believe our existing facilities are in good operating condition and are suitable for the conduct of our business. The facilities noted above are used mostly by all our reportable segments.

Item 2 of the 10-K filed Feb 27, 2026.16

The story

Align Technology was founded in 1997 by Zia Chishti and Kelsey Wirth, classmates at Stanford Graduate School of Business, and began working on the development of a clear aligner. Align received FDA clearance to market the Invisalign system in 1998, and it was first marketed in 2000. Align Technology went public on January 26, 2001, on the Nasdaq Stock Market.

In March 2011 Align acquired the Israeli company Cadent for $190 million; Cadent manufactured intraoral scanners that included 3D imaging, as well as software to display the acquired images and to plan treatment.

Joseph M. Hogan joined Align in June 2015, and is CEO and president.

The company's sales reached $1 billion for the first time in 2016 and its products were being used in about 8% of people who got braces. In 2017 the company was faced with the challenge of the expiration of its patents on its Invisalign system starting in October 2017 and the beginning of generic competition.

In March 2020, Align Technology announced that it has signed a definitive agreement to acquire exocad Global Holdings for approximately $418.7 million.

As of February 2023, Align Technology has assisted over 234,000 doctors and over 14.5 million patients worldwide.

In September 2023, it was announced Align Technology had acquired the Vienna-headquartered 3D printing technology and materials company, Cubicure GmbH.

From Wikipedia’s article on Align Technology, shared under CC BY-SA 4.0.7

Leadership

Who has led Align Technology, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Thomas M. Prescott2006–2015
  2. Joseph M. Hogan2015–now

President

  1. Thomas M. Prescott2006–2015
  2. Joseph M. Hogan2015–now

Chief financial officer

  1. Eldon M. Bullington2006–2007
  2. Emory Wright2007
  3. Kenneth Arola2007–2013
  4. John Morici2016–now
200020052010201520202025
Board members and other officers (48)

Products and brands

  • clear aligner

Listed on Wikidata.1

Timeline

  1. Aug 31, 20268-K Executive or director change70
  2. Jul 29, 20268-K Results of operations71
  3. Jul 29, 20268-K Regulation FD disclosure72
  4. Jul 9, 20268-K Executive or director change73
  5. Jun 22, 20268-K Executive or director change; Regulation FD disclosure74
  6. May 20, 20268-K Shareholder vote75
  7. May 1, 20268-K Regulation FD disclosure76
  8. Apr 29, 20268-K Results of operations77
  9. Feb 26, 20268-K Bylaws or fiscal year changed78
  10. Feb 4, 20268-K Results of operations79
  11. Oct 29, 20258-K Results of operations80
  12. Sep 18, 20258-K Executive or director change81
  13. Jun 1, 2015New chief executive Joseph M. Hogan becomes CEO1
  14. Feb 28, 2006New chief executive Thomas M. Prescott becomes CEO18
  15. 1997Founded Founded1

Calendar

Coming up

  1. Oct 28, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $2.07 a share, on Oct 29, 2025.82

When it reported results

  1. Jul 29, 2026Reported quarterly or annual results71
  2. Apr 29, 2026Reported quarterly or annual results77
  3. Feb 4, 2026Reported quarterly or annual results79
  4. Oct 29, 2025Reported quarterly or annual results80
  5. Jul 30, 2025Reported quarterly or annual results83
  6. Apr 30, 2025Reported quarterly or annual results84
  7. Feb 5, 2025Reported quarterly or annual results85
  8. Oct 23, 2024Reported quarterly or annual results86

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

252 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 53 major events, 116 insider forms, 24 large holders, 39 other. The latest 20:

  1. Aug 31, 20264 EDGAR
  2. Aug 31, 20263 EDGAR
  3. Aug 31, 20268-K EDGAR
  4. Aug 12, 2026SCHEDULE 13G/A EDGAR
  5. Aug 12, 2026SCHEDULE 13G/A EDGAR
  6. Aug 6, 2026SCHEDULE 13G EDGAR
  7. Aug 5, 202610-Q EDGAR
  8. Jul 29, 20268-K EDGAR
  9. Jul 29, 20268-K EDGAR
  10. Jul 9, 20268-K EDGAR
  11. Jun 22, 20268-K EDGAR
  12. May 29, 2026SD EDGAR
  13. May 22, 20264 EDGAR
  14. May 22, 20264 EDGAR
  15. May 22, 20264 EDGAR
  16. May 22, 20264 EDGAR
  17. May 22, 20264 EDGAR
  18. May 22, 20264 EDGAR
  19. May 22, 20264 EDGAR
  20. May 22, 20264 EDGAR

The 252 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

19 open-market trades by officers, directors and large owners since October 2021: 13 buys and 6 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Feb 18, 2026Morici JohnEVP, CHIEF FINANCIAL OFFICERSale7,969$189.31$1.5MForm 4
Aug 1, 2025HOGAN JOSEPH MPresident and CEOBuy7,576$131.49$996.2KForm 4
Jul 31, 2025Coletti Julie AnnEVP, CHIEF LEGAL & REGULATORYBuy42$109.66$4.6KForm 4
Aug 15, 2024LARKIN C RAYMOND JRDirectorBuy6,500$235.33$1.5MForm 4
Feb 29, 2024LACOB JOSEPHDirectorSale15,000$303.22$4.5MForm 4
Feb 27, 2024LACOB JOSEPHDirectorSale10,000$313.01$3.1MForm 4
Feb 7, 2024Wright EmoryEVP, GLOBAL OPERATIONSSale2,524$287.45$725.5KForm 4
Nov 9, 2023HOGAN JOSEPH MPresident and CEOBuy5,194$192.50$999.8KForm 4
Oct 31, 2023HOGAN JOSEPH MPresident and CEOBuy5,319$188.00$1.0MForm 4
May 30, 2023Dallas Kevin JDirectorBuy7,000$285.26$2.0MForm 4
Feb 8, 2023Morici JohnEVP, CHIEF FINANCIAL OFFICERBuy587$341.84$200.7KForm 4
Feb 8, 2023HOGAN JOSEPH MPresident and CEOBuy2,928$341.50$999.9KForm 4
Nov 2, 2022Thaler Warren SDirectorBuy1,050$191.21$200.8KForm 4
Nov 2, 2022Myong AnneDirectorBuy1,500$190.26$285.4KForm 4
Nov 2, 2022HOGAN JOSEPH MPresident and CEOBuy10,600$188.58$2.0MForm 4
May 13, 2022LARKIN C RAYMOND JRDirectorBuy1,000$264.42$264.4KForm 4
May 4, 2022HOGAN JOSEPH MPresident and CEOBuy6,700$298.48$2.0MForm 4
Nov 10, 2021Thaler Warren SDirectorSale5,000$703.06$3.5MForm 4
Nov 8, 2021Morici JohnEVP, CHIEF FINANCIAL OFFICERSale3,000$699.08$2.1MForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025John F. Morici,$697.7K$5.7M96
2025Julie ColettiExecutive Vice President, Chief Legal and Regulatory Officer$644.2K$4.5M96
2025Stuart Hockridge,$537.7K$2.8M96
2025Joseph M. Hogan,$1.4M$396
2024President and Chief Executive Officer$1.4M$27.3M96
2024Chief Financial Officer and Executive Vice PresidentGlobal Finance$675.4K$6.4M96
2024Julie ColettiExecutive Vice President, Chief Legal and Regulatory Officer$597.7K$4.8M96
2024Executive Vice PresidentGlobal Human Resources$518.5K$3.5M96
2023President and Chief Executive Officer$1.4M$29.0M96
2023Chief Financial Officer and Executive Vice PresidentGlobal Finance$618.5K$5.6M96
2023Julie ColettiExecutive Vice President, Chief Legal and Regulatory Officer$566.2K$4.3M96
2023Executive Vice PresidentGlobal Human Resources$498.5K$3.4M96

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.4,419,366$745.4M0.0%+129,442
Vanguard Capital Management LLC4,401,313$742.3M0.0%+12,194
Fmr LLC4,060,032$684.8M0.0%+1,359,673
Capital International Investors4,045,561$682.3M0.1%+236,359
Capital World Investors3,422,385$577.2M0.1%−649,911
Goldman Sachs Group Inc3,372,760$568.8M0.1%+1,576,509
Vanguard Portfolio Management LLC3,131,764$528.2M0.0%−19,019
State Street Corp2,558,512$431.5M0.0%+42,258
Geode Capital Management, LLC2,245,315$378.2M0.0%+454,611
Ninety One UK Ltd2,209,791$372.7M0.8%−18,423
UBS Group AG2,125,286$358.5M0.1%+720,131
Kayne Anderson Rudnick Investment Management LLC1,733,484$292.4M0.9%−169,421
Dimensional Fund Advisors LP1,438,900$242.7M0.0%+466,381
Invesco Ltd.1,413,567$238.4M0.0%+101,053
Assenagon Asset Management S.A.1,262,306$212.9M0.1%+272,918
Ruane, Cunniff & Goldfarb L.P.1,171,455$197.6M3.1%−35,080
Arrowstreet Capital, Limited Partnership1,071,601$180.7M0.1%+16,968
Jacobs Levy Equity Management, Inc1,068,964$180.3M0.6%+37,640
Morgan Stanley1,013,842$171.0M0.0%+520
Norges Bank904,623$152.6M0.0%New
Aqr Capital Management LLC899,731$151.2M0.1%+6,525
Jpmorgan Chase & Co773,182$134.7M0.0%+12,380
Disciplined Growth Investors Inc /mn783,178$132.1M2.2%+7,352
Senvest Management, LLC745,345$125.7M3.7%−9,452
Charles Schwab Investment Management Inc668,129$112.7M0.0%+24,646

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

21 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Sep 11, 2025Lisa C. McClainRepublican, HouseSale$1,001 - $15,000+9.0%Report
Aug 4, 2025Lisa C. McClainRepublican, HouseBuy$1,001 - $15,000−15.4%Report
Apr 8, 2025Robert P. Bresnahan, Jr.Republican, HouseSale$1,001 - $15,000+53.4%Report
Feb 26, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseSale$1,001 - $15,000+52.8%Report
Feb 25, 2025Robert P. Bresnahan, Jr.Republican, HouseBuy$1,001 - $15,000−50.9%Report
May 20, 2024Josh GottheimerDemocratic, HouseSale$1,001 - $15,000+90.5%Report
Oct 27, 2023Josh GottheimerDemocratic, HousePartial sale$1,001 - $15,000+110.8%Report
Aug 22, 2023Dan SullivanRepublican, SenateSale$1,001 - $15,000+134.3%Report
Mar 6, 2023Josh GottheimerDemocratic, HouseBuy$1,001 - $15,000−146.9%Report
Jan 27, 2023Josh GottheimerDemocratic, HouseBuy$1,001 - $15,000−135.5%Report
Jan 10, 2023Dan SullivanRepublican, SenateBuy$1,001 - $15,000−134.2%Report
Oct 5, 2022Tommy TubervilleRepublican, SenateSale$1,001 - $15,000+140.3%Report
Jun 15, 2022Kathy Manning, HouseSale$15,001 - $50,000+143.1%Report
Apr 28, 2022Josh GottheimerDemocratic, HouseSale$1,001 - $15,000+132.1%Report
Feb 1, 2022Josh GottheimerDemocratic, HousePartial sale$1,001 - $15,000+141.4%Report
Jan 31, 2022Josh GottheimerDemocratic, HousePartial sale$1,001 - $15,000+141.8%Report
Mar 29, 2021Tommy TubervilleRepublican, SenateBuy$1,001 - $15,000−166.5%Report
Mar 15, 2021Josh GottheimerDemocratic, HouseBuy$1,001 - $15,000−168.3%Report
Nov 11, 2020Josh GottheimerDemocratic, HouseBuy$1,001 - $15,000−184.5%Report
Nov 6, 2020Josh GottheimerDemocratic, HouseBuy$1,001 - $15,000−189.6%Report
Jun 10, 2020Gilbert Ray Cisneros, Jr.Democratic, HousePartial sale$1,001 - $15,000+186.9%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Align Technology is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARALIGN TECHNOLOGY INC2
  • CIK0001097149
  • Employer ID (EIN)94-326729516
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company16
  • Incorporated inDelaware16
  • Fiscal year endsDecember 312
  • Industry code (SIC)3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business address410 North Scottsdale Road, Suite 1300, Tempe, AZ 852882
  • Phone408-470-10002
  • Shares outstanding71,039,852 as of Jul 31, 202614
  • Public float$11.1B as of Jun 30, 202516
  • AuditorPricewaterhouseCoopers LLP, San Jose, California PCAOB ID 238; it also attests to the company’s internal control over financial reporting16
  • On EDGAR sinceNov 14, 20002
  • Filings2,119 in all: 4 (1,326), 8-K (283), SC 13G/A (94), 10-Q (77), 3 (51), 4/A (41), SC 13G (28), DEF 14A (27)2
    All 42 form types

    10-K (25), 144 (24), 5 (16), S-8 (14), DEFA14A (13), SD (13), S-8 POS (10), UPLOAD (10), 8-K/A (9), CORRESP (8), SCHEDULE 13G/A (6), ARS (5), PRE 14A (5), SCHEDULE 13G (5), S-1/A (3), SC 13D/A (3), 10-K/A (2), 10-Q/A (2), 424B3 (2), 5/A (2), 8-A12G (2), 10-K405 (1), 10-K405/A (1), 3/A (1), 424B4 (1), CT ORDER (1), D (1), DEFR14A (1), POS AM (1), REGDEX (1), S-1 (1), S-3 (1), S-3/A (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Feb 27, 2026
    Quarterly report (10-Q) Aug 5, 2026
    Proxy statement (DEF 14A) Apr 7, 2026
    Latest 8-K (8-K) Aug 31, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, $0.0001 par valueALGNThe Nasdaq Stock Market LLC

From the cover page of the 10-K filed Feb 27, 2026 (Section 12(b) of the Exchange Act).16

Risk factors and legal proceedings

The risks Align Technology names in Item 1A of its 10-K filed Feb 27, 2026: 36 risks under these headings, as written.16

  • Macroeconomic and External Risks
  • Global and regional economic conditions have and could in the future materially affect our business, financial condition and results of operations.
  • We are subject to foreign currency exchange fluctuations, which could have a material adverse effect on our financial condition or results of operations.
  • Geopolitical events, tariffs and trade policies, and military conflicts have and could in the future materially affect our business, financial condition and results of operations.
  • Natural disasters may adversely impact our business, financial condition and results of operations, as well as those of our customers and consumers, suppliers, contract manufacturers, commercial intermediaries and other business partners.
  • Business and Industry Risks
  • Demand for our products and services may not increase or may decrease for many reasons, including resistance to the innovative and business-model-disruptive nature of some of our products and services.
  • Our net revenues depend primarily on sales of the Invisalign System and iTero intraoral scanners and declines in volume or the average selling price (“ASP”) may adversely affect net revenues, gross profit, operating profit and net income.
  • Competition in the markets for our products and services is increasing.
  • Our success depends on our ability to quickly and profitably develop, manufacture, market, and obtain and maintain regulatory approvals or clearances of new, improved or refurbished products and services.
  • We may not realize the anticipated benefits of acquisitions, investments or other strategic transactions, and they may require significant management attention, disrupt our business, dilute stockholder value or adversely affect our business, financial condition and results of operations.
  • Operational Risks
The other 27 risks
  • Our quarterly and annual results of operations have and will continue to fluctuate in the future, and we may not accurately predict the timing and amount of customer demand and our revenues, costs, and expenditures.
  • Our results of operations may be adversely affected if doctors at DSOs, orthodontic service organizations (“OSOs”) or other large group practices reduce, delay, or do not increase their purchasing of our products and services in ways that reduce adoption of our products and services.
  • We are subject to operating risks, including excess or constrained capacity, operational inefficiencies and pressure on our internal systems, personnel and suppliers, including as a result of our past and any future restructuring efforts, which could adversely affect our results of operations.
  • Security breaches, data breaches, cybersecurity attacks, or other cybersecurity incidents could materially adversely impact our operations and patient care, and our reputation, business, financial condition and results of operations could be harmed.
  • Issues with IT system and software integration, implementation, updates, and upgrades, or third-party software have previously and could again in the future disrupt our operations.
  • Products in our Systems and Services segment, such as our iTero intraoral scanners, are subject to software and hardware risks that, if improperly managed, could have a material adverse impact on our business and financial results.
  • We are highly dependent on third-party suppliers, some of whom are sole source suppliers, for certain key machines, components and materials, and our business, financial condition and results of operations could be materially adversely affected if supply is restricted or ends or the price materially increases.
  • We contract with commercial intermediaries to distribute a portion of the importation, marketing and sales of our products and services, which exposes us to risks to our sales, operations and reputation, including the risk these intermediaries do not comply with applicable laws or our internal procedures.
  • A disruption in the operations of a primary freight carrier, higher shipping costs or shipping delays could disrupt our supply chain and impact our operating and financial results.
  • If we cannot attract, motivate, train or retain personnel, it will be difficult to achieve our strategic priorities, which could materially adversely affect our business, financial condition and results of operations.
  • We depend on our marketing activities to deepen our market penetration and raise awareness of our brands, products, and services, which may prove unsuccessful or may become less effective or more costly to maintain in the long term.
  • Legal, Regulatory and Compliance Risks
  • We are subject to antitrust and competition regulations, litigation and enforcement that may result in fines, penalties, restrictions on our business practices, and product, services or operational changes which could materially impact our business, financial condition and results of operations.
  • Failure to obtain or maintain approvals or comply with regulations and government actions regarding our products or services or those of our suppliers could materially harm our sales, result in substantial penalties and fines, interrupt our supply chain and cause harm to our reputation.
  • We are subject to various laws relating to privacy, data protection, data governance and cybersecurity, and face risks related to the data we collect, process, and share.
  • Our business exposes us to potential liability for the quality and safety of our products and services, how we advertise and market those products and services, and how and to whom we sell them, and we may incur substantial expenses or be found liable for substantial damages or penalties if we are subject to claims or litigation.
  • Current and anticipated sustainability and social (“Sustainability”) laws and scrutiny of our Sustainability policies and practices may materially increase our costs, expose us to liability, and adversely impact our reputation, employee retention, willingness of customers and suppliers to do business with us and willingness of investors to invest in us.
  • AI and machine learning technologies in our products, services and IT systems may result in legal and regulatory risks, reputational harm or have other adverse consequences to our business.
  • Intellectual Property Risks
  • Our success depends in part on our proprietary technology, and if we fail to successfully obtain or enforce our IP rights, our competitive position may be harmed.
  • Litigation regarding our IP rights, rights claimed by third parties or IP litigation by any vendors on whose products or services we rely for our products and services may impact our ability to grow our business and adversely impact our reputation and results of operations.
  • Financial, Tax and Accounting Risks
  • If our goodwill, finite-lived intangible or long-lived assets become impaired, we may be required to record material charges to income.
  • Changes in, or interpretations of, accounting rules and regulations, could result in unfavorable accounting charges.
  • We are required to annually assess our internal control over financial reporting and any adverse results from such assessment may result in a loss of investor confidence in our financial reports and adversely affect our stock price.
  • Our effective tax rate may vary significantly from period to period, which could result in volatility of our operating results and adversely affect our financial results.
  • New tax laws and practices, changes to existing tax laws and practices, or disputes regarding the positions we take regarding tax laws, could negatively affect our provision for income taxes as well as our ongoing operations.
  • Risks Related to Ownership of our Common Stock
  • Historically, the market price for our common stock has been volatile.
  • We may not continue repurchasing our common stock and any repurchases may not achieve our desired objectives.
  • Future sales of significant amounts of our common stock may depress our stock price.

Legal proceedings

The information set forth in Note 8 “Legal Proceedings” of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K is incorporated herein by reference.

The opening of Item 3, Legal Proceedings.16

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
    Wikidata and SEC EDGARKevin T. Conroy, Board member
  55. 55
    Wikidata and SEC EDGARMojdeh Poul, Board member
  56. 56
    Wikidata and SEC EDGARAnne M. Myong, Board member
  57. 57
    Wikidata and SEC EDGARKevin J. Dallas, Board member
  58. 58
    Wikidata and SEC EDGARSusan E. Siegel, Board member
  59. 59
    Wikidata and SEC EDGARAndrea L. Saia, Board member
  60. 60
  61. 61
    Wikidata and SEC EDGARGeorge J. Morrow, Board member
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
    Wikidata and SEC EDGARJoe Lacob, Board member
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96